Latest News & Updates

Breaking News

  • 6 minutes ago

  • Vaibhavi M.

Alexion Advances Paediatric HSCT-TMA Regulatory Filings Despite Ultomiris Misses Primary Endpoint in Phase III Adult HSCT-TMA Trial
Breaking News
Sone-Ve Demonstrates Significant Overall Survival Benefit in Phase III Gastric Cancer Trial

Vaibhavi M.

Idorsia Partners With Jamjoom Pharma to Commercialize QUVIVIQ In Saudi Arabia and Levant Expands Global Reach

Vaibhavi M.

Revagenix Doses First Participant In Phase 1 Trial Of Rev-56 For Non-Cystic Fibrosis Bronchiectasis

Simantini Singh Deo

Cato Healthcare Supply Appoints Ryan F. Zackon As President And Chief Executive Officer

Simantini Singh Deo

Other trending news you may like to read

Alexion Advances Paediatric HSCT-TMA Regulatory Filings Despite Ultomiris Misses Primary Endpoint in Phase III Adult HSCT-TMA Trial

Alexion advances pediatric HSCT-TMA filings despite Ultomiris missing its adult Phase III endpoint.

Vaibhavi M.

Pharma Now

Sone-Ve Demonstrates Significant Overall Survival Benefit in Phase III Gastric Cancer Trial

Sone-Ve demonstrates significant overall survival benefit in Phase III gastric cancer trial.

Vaibhavi M.

Pharma Now

Idorsia Partners With Jamjoom Pharma to Commercialize QUVIVIQ In Saudi Arabia and Levant Expands Global Reach

Idorsia partners with Jamjoom Pharma to commercialize QUVIVIQ in Saudi Arabia and the Levant.

Vaibhavi M.

Pharma Now

Revagenix Doses First Participant In Phase 1 Trial Of Rev-56 For Non-Cystic Fibrosis Bronchiectasis

Revagenix doses first participant in Phase 1 trial of Rev-56 for non-cystic fibrosis bronchiectasis.

Simantini Singh Deo

Pharma Now